These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17334228)

  • 1. Psammaplin A is a natural prodrug that inhibits class I histone deacetylase.
    Kim DH; Shin J; Kwon HJ
    Exp Mol Med; 2007 Feb; 39(1):47-55. PubMed ID: 17334228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent analogs of the marine natural product psammaplin A: synthesis and biological activity.
    Hentschel F; Sasse F; Lindel T
    Org Biomol Chem; 2012 Sep; 10(35):7120-33. PubMed ID: 22872318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets.
    Baud MG; Leiser T; Haus P; Samlal S; Wong AC; Wood RJ; Petrucci V; Gunaratnam M; Hughes SM; Buluwela L; Turlais F; Neidle S; Meyer-Almes FJ; White AJ; Fuchter MJ
    J Med Chem; 2012 Feb; 55(4):1731-50. PubMed ID: 22280363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
    Ahn MY; Jung JH; Na YJ; Kim HS
    Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
    Eikel D; Lampen A; Nau H
    Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases.
    Furumai R; Matsuyama A; Kobashi N; Lee KH; Nishiyama M; Nakajima H; Tanaka A; Komatsu Y; Nishino N; Yoshida M; Horinouchi S
    Cancer Res; 2002 Sep; 62(17):4916-21. PubMed ID: 12208741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indole-derived psammaplin A analogues as epigenetic modulators with multiple inhibitory activities.
    Pereira R; Benedetti R; Pérez-Rodríguez S; Nebbioso A; García-Rodríguez J; Carafa V; Stuhldreier M; Conte M; Rodríguez-Barrios F; Stunnenberg HG; Gronemeyer H; Altucci L; de Lera AR
    J Med Chem; 2012 Nov; 55(22):9467-91. PubMed ID: 23030799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.
    Khan N; Jeffers M; Kumar S; Hackett C; Boldog F; Khramtsov N; Qian X; Mills E; Berghs SC; Carey N; Finn PW; Collins LS; Tumber A; Ritchie JW; Jensen PB; Lichenstein HS; Sehested M
    Biochem J; 2008 Jan; 409(2):581-9. PubMed ID: 17868033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assay for inhibitory activity of histone deacetylase].
    Yoshida M
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):507-11. PubMed ID: 15114691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of non-hydroxamate histone deacetylase inhibitors: identification of a selective histone acetylating agent.
    Suzuki T; Matsuura A; Kouketsu A; Hisakawa S; Nakagawa H; Miyata N
    Bioorg Med Chem; 2005 Jul; 13(13):4332-42. PubMed ID: 15927839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Camptothecin-psammaplin A hybrids as topoisomerase I and HDAC dual-action inhibitors.
    Cincinelli R; Musso L; Artali R; Guglielmi M; Bianchino E; Cardile F; Colelli F; Pisano C; Dallavalle S
    Eur J Med Chem; 2018 Jan; 143():2005-2014. PubMed ID: 29150335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A homogeneous cellular histone deacetylase assay suitable for compound profiling and robotic screening.
    Ciossek T; Julius H; Wieland H; Maier T; Beckers T
    Anal Biochem; 2008 Jan; 372(1):72-81. PubMed ID: 17868634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking procedures.
    Mai A; Massa S; Ragno R; Cerbara I; Jesacher F; Loidl P; Brosch G
    J Med Chem; 2003 Feb; 46(4):512-24. PubMed ID: 12570373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly ligand efficient and selective N-2-(Thioethyl)picolinamide histone deacetylase inhibitors inspired by the natural product psammaplin A.
    Baud MG; Haus P; Leiser T; Meyer-Almes FJ; Fuchter MJ
    ChemMedChem; 2013 Jan; 8(1):149-56. PubMed ID: 23184734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.
    Bora-Tatar G; Dayangaç-Erden D; Demir AS; Dalkara S; Yelekçi K; Erdem-Yurter H
    Bioorg Med Chem; 2009 Jul; 17(14):5219-28. PubMed ID: 19520580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of histone deacetylase inhibitors for cancer treatment.
    Marchion D; Münster P
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):583-98. PubMed ID: 17428177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psammaplins from the sponge Pseudoceratina purpurea: inhibition of both histone deacetylase and DNA methyltransferase.
    Piña IC; Gautschi JT; Wang GY; Sanders ML; Schmitz FJ; France D; Cornell-Kennon S; Sambucetti LC; Remiszewski SW; Perez LB; Bair KW; Crews P
    J Org Chem; 2003 May; 68(10):3866-73. PubMed ID: 12737565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamazepine is an inhibitor of histone deacetylases.
    Beutler AS; Li S; Nicol R; Walsh MJ
    Life Sci; 2005 May; 76(26):3107-15. PubMed ID: 15850602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
    Chen J; Du C; Kang J; Wang J
    Chem Biol Interact; 2008 Jan; 171(1):26-36. PubMed ID: 17961528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.